About
Technology
Issues
FAQ
Links
Official Page
Pre‐clinical evidence for the use of phosphodiesterase‐5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.